Your browser doesn't support javascript.
loading
Rescue left bundle branch area pacing in coronary venous lead failure or nonresponse to biventricular pacing: Results from International LBBAP Collaborative Study Group.
Vijayaraman, Pugazhendhi; Herweg, Bengt; Verma, Atul; Sharma, Parikshit S; Batul, Syeda Atiqa; Ponnusamy, Shunmuga Sundaram; Schaller, Robert D; Cano, Oscar; Molina-Lerma, Manuel; Curila, Karol; Huybrechts, Wim; Wilson, David R; Rademakers, Leonard M; Sreekumar, Praveen; Upadhyay, Gaurav; Vernooy, Kevin; Subzposh, Faiz A; Huang, Weijian; Jastrzebski, Marek; Ellenbogen, Kenneth A.
Afiliación
  • Vijayaraman P; Geisinger Heart Institute, Wilkes-Barre, Pennsylvania. Electronic address: pvijayaraman1@geisinger.edu.
  • Herweg B; Division of Cardiology, University of South Florida, Tampa, Florida.
  • Verma A; South Lake Regional Health Center, University of Toronto, Toronto, Canada.
  • Sharma PS; Rush University Medical Center, Chicago, Illinois.
  • Batul SA; Geisinger Heart Institute, Wilkes-Barre, Pennsylvania.
  • Ponnusamy SS; Department of Cardiology, Velammal Medical College Hospital and Research Institute, Velammal Village, Madurai, Tamil Nadu, India.
  • Schaller RD; Division of Cardiovascular Medicine, Electrophysiology Section, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Cano O; Hospital Universitari i Politècnic La Fe, Valencia, Spain, and Centro de Investigaciones Biomédicas en RED en Enfermedades Cardiovasculares (CIBERCV).
  • Molina-Lerma M; Virgen de las Nieves Hospital, Granada, Spain.
  • Curila K; Cardiocenter, University Hospital Kralovske Vinohrady and 3rd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
  • Huybrechts W; Department of Cardiology, University Hospital Antwerp, Belgium.
  • Wilson DR; Division of Cardiology, University of South Florida, Tampa, Florida.
  • Rademakers LM; Department of Cardiology, Catharina Ziekenhuis, Eindhoven, The Netherlands.
  • Sreekumar P; Electrophysiology Unit, Department of Cardiology Aster Medcity, Kochi, Kerala, India.
  • Upadhyay G; University of Chicago, Chicago, Illinois.
  • Vernooy K; Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre+ (MUMC+), Maastricht, The Netherlands.
  • Subzposh FA; Geisinger Heart Institute, Wilkes-Barre, Pennsylvania.
  • Huang W; Department of Cardiology, the First Affiliated Hospital of Wenzhou Medical University, and The Key Lab of Cardiovascular Disease of Wenzhou, Wenzhou, China.
  • Jastrzebski M; First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University, Medical College, Krakow, Poland.
  • Ellenbogen KA; Virginia Commonwealth University Health System, Richmond, Virginia.
Heart Rhythm ; 19(8): 1272-1280, 2022 08.
Article en En | MEDLINE | ID: mdl-35504539
BACKGROUND: Cardiac resynchronization therapy (CRT) using biventricular pacing (BVP) is effective in patients with heart failure, left bundle branch block (LBBB), and reduced left ventricular function. Left bundle branch area pacing (LBBAP) has been reported as an alternative option for CRT. OBJECTIVE: The purpose of this study was to assess the feasibility and outcomes of LBBAP in patients who failed conventional BVP because of coronary venous (CV) lead complications or who were nonresponders to BVP. METHODS: At 16 international centers, LBBAP was attempted in patients with conventional CRT indication who failed BVP because of CV lead complications or lack of therapeutic response to BVP. Heart failure hospitalization (HFH) and death, echocardiographic outcomes, procedural data, pacing parameters, and lead complications including CV lead failure are reported. RESULTS: LBBAP was successfully performed in 200 patients (CV lead failures 156; nonresponders 44) (age 68 ± 11 years; female 35%; LBBB 55%; right ventricular pacing 23%; ischemic cardiomyopathy 28%; nonischemic cardiomyopathy 63%; left ventricular ejection fraction [LVEF] ≤35% in 80%). Procedural duration was 119.5 ± 59.6 minutes, and fluoroscopy duration was 25.7 ± 18.5 minutes. LBBAP threshold and R-wave amplitudes were 0.68 ± 0.35 V @ 0.45 ms and 10.4 ± 5 mV at implant, respectively, and remained stable during mean follow-up of 12 ± 10.1 months. LBBAP resulted in significant QRS narrowing from 170 ± 28 ms to 139 ± 25 ms (P <.001) with V6 R-wave peak times of 85 ± 17 ms. LVEF improved from 29% ± 10% at baseline to 40% ± 12% (P <.001) during follow-up. The risk of death or HFH was lower in those with CV lead failure than in nonresponders (hazard ratio 0.357; 95% confidence interval 0.168-0.756; P = .007) CONCLUSION: LBBAP is a viable alternative to CRT in patients who failed conventional BVP due to CV lead failure or who were nonresponders.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Terapia de Resincronización Cardíaca / Insuficiencia Cardíaca Tipo de estudio: Diagnostic_studies / Etiology_studies Límite: Aged / Female / Humans / Middle aged Idioma: En Revista: Heart Rhythm Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Terapia de Resincronización Cardíaca / Insuficiencia Cardíaca Tipo de estudio: Diagnostic_studies / Etiology_studies Límite: Aged / Female / Humans / Middle aged Idioma: En Revista: Heart Rhythm Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos